Skip to main content
. 2018 Sep 22;71(3):270–275. doi: 10.5173/ceju.2018.1749

Table 2.

Tumour characteristics

Gleason score Patient group
Gleason 6 89/159 = 56%
Gleason 3 + 4 58/159 = 36.5%
Gleason 4 + 3 12/159 = 7.5%

Tumour stage Patient group

cT1c 129/159 = 81%
cT2a 30/159 = 19%

Percentage of positive biopsies Patient group

<50% 131/159 = 82%
≥50% 28/159 = 18%

Gleason score preoperatively Percentage of tumour recurrence

Gleason 6 3/89 = 3.4%
Gleason 7 6/70 = 8.6%